Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC

Oxurion NV, based in Leuven, Belgium, has announced a transparency notification in compliance with Belgian legislation. On May 22, 2026, Atlas Special Opportunities II, LLC notified Oxurion that as of May 21, 2026, it held 4,320,175 shares, falling below the 5% threshold, with a total of 88,691,312 shares outstanding.

This notification indicates a reduction in Atlas's voting securities, reflecting their sales activity. Oxurion is known for acquiring stakes in European pharmaceutical subcontractors, aiming to integrate them into a cohesive group serving healthcare entities.

Forward-looking statements in this announcement reflect current expectations and entail risks. Oxurion advises caution regarding these statements, as market conditions can affect outcomes. The company is also diversifying with planned investments in digital assets, acknowledging potential risks like volatility and regulatory changes.